Adjunctive acne therapies;Ergänzende verfahren in der aknetherapie

JDDG - Journal of the German Society of Dermatology

Volumn 3, Issue 2, 2005, Pages 92-96

  Degitz, Klaus ^a,b   Plewig, Gerd ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acne; Dapsone; Phototherapy; Zinc

Indexed keywords

ABRASIVE AGENT; ALUMINUM OXIDE; ANTIANDROGEN; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; COMEDOLYTIC AGENT; DAPSONE; ERYTHROMYCIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; ISOTRETINOIN; MINOCYCLINE; UNCLASSIFIED DRUG; ZINC;

ACNE; ADJUVANT THERAPY; COMEDO; COMEDONE EXTRACTION; DIODE LASER; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; LOW LEVEL LASER THERAPY; METHEMOGLOBINEMIA; PERIPHERAL NEUROPATHY; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PROPIONIBACTERIUM ACNES; REVIEW; ULTRAVIOLET RADIATION;

ACNE VULGARIS; ANTI-INFECTIVE AGENTS; COMBINED MODALITY THERAPY; DAPSONE; DEBRIDEMENT; DERMATOLOGIC AGENTS; HUMANS; PHOTOCHEMOTHERAPY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TREATMENT OUTCOME; ZINC;

EID: 13844253620     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1610-0378.2005.04087.x     Document Type: Review

References (51)

1. Plewig G, Kligman AM. Acne and rosacea, 3rd edn. Berlin: Springer, 2000.
2. Gollnick HP, Cunliffe WJ. Management of acne. A report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003; 49: S1-S38.
3. Ross CM. The treatment of acne vulgaris with dapsone. Br J Dermatol 1961; 73: 367-370.
4. Prendiville JS, Logan RA, Russell Jones R. A comparison of dapsone with 13-cis retinoic acid in the treatment of nodular cystic acne. Clin Exp Dermatol 1988; 13: 67-71.
5. Tan BB, Lear JT, Smith AG. Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone. Clin Exp Dermatol 1997; 22: 26-27.
6. Hofer T, Itin PH. Acne inversa. Eine Dapson-sensitive Dermatose. Hautarzt 2001; 52: 989-992.
7. Lutz GA. Zinksalze. In: Korting HC, Sterry W: Therapeutische Verfahren in der Dermatologie: Dermatika und Kosmetika. Berlin: Blackwell, 2001: 607-614.
8. Dreno B, Amblard P, Agache P, Sirot S, Litoux P. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol 1989; 69: 541-543.
9. Hillstrom L, Pettersson L, Hellbe L, Kjellin A, Leczinsky CG, Nordwall C. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol 1977; 97: 681-684.
10. Michaelsson G, Juhlin L, Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol 1977; 113: 31-36.
11. Goransson K, Liden S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol 1978; 58: 443-448.
12. Weimar VM, Puhl SC, Smith WH, TenBroeke JE. Zinc sulfate in acne vulgaris. Arch Dermatol 1978; 114: 1776-1778.
13. Verma KC, Saini AS, Dhamija SK. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol 1980; 60: 337-340.
14. Orris L, Shalita AR, Sibulkin D, London SJ, Gans EH. Oral zinc therapy of acne. Absorption and clinical effect. Arch Dermatol 1978; 114: 1018-1020.
15. Weismann K, Wadskov S, Sondergaard J. Oral zinc sulphate therapy for acne vulgaris. Acta Derm Venereol 1977; 57: 357-360.
16. Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, Bodokh I, Chivot M, Daniel F, Humbert P, Meynadier J, Poli F. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001; 203: 135-140.
17. Michaelsson G, Juhlin L, Ljunghall K. A double-blind study of the effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol 1977; 97: 561-566.
18. Cunliffe WJ, Burke B, Dodman B, Gould DJ. A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris. Br J Dermatol 1979; 101: 321-325.
19. Cochran RJ, Tucker SB, Flannigan SA. Topical zinc therapy for acne vulgaris. Int J Dermatol 1985; 24: 188-190.
20. Holland KT, Bojar RA, Cunliffe WJ, Cutcliffe AG, Eady EA, Farooq L, Farrell AM, Gribbon EM, Taylor D. The effect of zinc and erythromycin on the growth of erythromycin-resistant and erythromycin-sensitive isolates of propionibacterium acnes: an in-vitro study. Br J Dermatol 1992; 126: 505-509.
21. Bojar RA, Eady EA, Jones CE, Cunliffe WJ, Holland KT. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol 1994; 130: 329-336.
22. Feucht CL, Allen BS, Chalker DK, Smith JG. Topical erythromycin with zinc in acne. A double-blind controlled study. J Am Acad Dermatol 1980; 3: 483-491.
23. Schachner L, Eaglstein W, Kittles C, Mertz P. Topical erythromycin and zinc therapy for acne. J Am Acad Dermatol 1990; 22: 253-260.
24. Habbema L, Koopmans B, Menke HE, Doornweerd S, De Boulle K. A 4% erythromycin and zinc combination (Zineryt) versus 2 % erythromycin (Eryderm) in acne vulgaris: a randomized, double-blind comparative study. Br J Dermatol 1989; 121: 497-502.
25. Ernst E, Huntley A. Tea tree oil: A systematic review of randomized clinical trials. Forsch Komplementärmed 2000; 7: 17-20.
26. Raman A, Weir U, Bloomfield SF. Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis and Propionibacterium acnes. Lett Appl Microbiol 1995; 21: 242-245.
27. Bassett IB, Pannowitz DL, Barnetson RS. A comparative study od tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990; 153: 455-458.
28. Carson CF, Riley TV. Safety, efficacy and provenance of tea tree (melaleuca alternifolia) oil. Contact dermatitis 2001; 45: 65-67.
29. Mills OH, Kligman AM. Ultraviolet phototherapy and photochemotherapy of acne vulgaris. Arch Dermatol 1978; 114: 221-223.
30. Meffert H, Kölzsch J, Laubstein B, Sönnichsen N. Phototherapie der Akne mit dem Teilkörperbestrahlungsgerät ",TuR" UV10. Dermatol Monatsschr 1986; 172: 9-13.
31. Mills OH, Porte M, Kligman AM. Enhancement of comedogenic substances by ultraviolet radiation. Br J Dermatol 1978; 98: 145-150.
32. Motoyoshi K. Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br J Dermatol 1983; 109: 191-198.
33. Arakane K, Ryu A, Hayashi C, Masunaga T, Shinmoto K, Mashiko S, Nagano T, Hirobe M. Singlet oxygen (1 Delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation. Biochem Biophys Res Commun 1996; 223: 578-582.
34. Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne. Br J Dermatol 2000; 142: 973-978.
35. Meffert H, Gaunitz K, Gutewort T, Amlong UJ. Aknetherapie mit sichtbarem Licht. Dermatol Monatsschr 1990; 176: 597-603.
36. Sigurdsson V, Knulst AC, Van Weelden H. Phototherapy of acne vulgaris with visible light. Dermatology 1997; 194: 256-260.
37. Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T. Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation. J Dermatol Sci 2002; 30: 129-135.
38. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115: 183-192.
39. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanaese patients. Br J Dermatol 2001; 144: 575-579.
40. Seaton ED, Charakida A, Mouser PE, Grace I, Clement RM, Chu AC. Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial. Lancet 2003; 362: 1347-1352.
41. Orringer JS, Kang S, Hamilton T, Schumacher W, Cho S, Hammerberg C, Fisher GJ, Karimipour DJ, Johnson TM, Vorhees JJ. Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial. JAMA 2004; 291: 2834-2839.
42. Friedman PM, Jih MH, Kimyai-Asadi A, Goldberg LH. Treatment of inflammatory facial acne vulgaris with the 1450-nm diode laser: a pilot study. Dermatol Surg 2004; 30: 147-151.
43. Michelsen S, Plewig G. Fruchtsäurebehandlung bei Aknetherapie. Hautarzt 1996; 47: 311-312.
44. Fratila A. Fruchtsäurebehandlung bei Aknetherapie. Hautarzt 1996; 47: 937-938.
45. Van Scott EJ, Ruey JY. Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol 1984; 11: 867-879.
46. Atzori L, Brundu MA, Orru A, Biggio P. Glycolic acid peeling in the treatment of acne. J Eur Acad Dermatol Venerol 1999; 12: 119-122.
47. Cotellesa C, Manunta T, Ghersetich I, Brazzini B, Peris K. The use of pyruvic acid in the treatment of acne. J Eur Acad Dermatol Venerol 2004; 18: 275-278.
48. Erbagci Z, Akcali C. Biweekly serila glycolic acid peels vs. long-term daily use of topical low-strength glycolic acid in the treatment of atrophic acne scars. Int J Dermatol 2000; 39: 789-794.
49. Mills OH, Kligman AM. Evaluation of abrasives in acne therapy. Cutis 1979; 23: 704-705.
50. Fulghum DD, Catalane PM, Childers RC, Cullen SI, Engel MF. Abrasive cleansing in the management of acne vulgaris. Arch Dermatol 1982; 118: 658-659.
51. Sackett DL, Strauss SE, Richardson WS, Rosenberg W, Hayned RB. Evidence-based medicine. Edinburgh: Churchill-Livingstone, 2000.